RESTASIS MULTIDOSE
RESTASIS MULTIDOSE
Approved
DIN Number
02476835
Drug Class
Human
Market Date
Aug 9, 2018
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02476835
AIG Number0115996006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01XA18 CICLOSPORIN
Product Specifications
Dosage FormEmulsion
Route of AdministrationOphthalmic
AHFS Classification52:08.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CYCLOSPORINEActive
Strength: 0.05 % / W/V
Monograph: CYCLOSPORINE